Results 101 to 110 of about 30,955 (215)

Reducing the clinical burden of ranibizumab treatment for neovascular age-related macular degeneration using an individually planned regimen. [PDF]

, 2014
AIMS: The purpose of this study was to clinically validate an individually planned treatment regimen for neovascular age-related macular degeneration (nAMD), termed, observe and plan.
Ambresin, A., Deli, A., Gianniou, C., Mantel, I., Niderprim, S.A.   +4 more
core   +1 more source

Intravitreal anti‐vascular endothelial growth factor injections and risks of stroke in patients with neovascular age‐related macular degeneration—A registry‐based cohort study

Acta Ophthalmologica, Volume 104, Issue 1, Page 98-105, February 2026.
Abstract Background Intravitreal Anti‐Vascular Endothelial Growth Factor (VEGF) rescues retinal vasculatures and prevents disease progression in patients with neovascular Age‐Related Macular Degeneration (nAMD). However, systemic anti‐VEGF may increase the risk of thromboembolic related complications including stroke and TIA. This study aims to explore
A. H. Falemban, K. Söderberg‐Löfdal, F. Jonsson, S. Almlöf‐Sarman, M. von Euler, I. Westborg   +5 more
wiley   +1 more source

Neovascular Age-related Macular Degeneration

, 2022
This thesis describes the treatment of exudative Age-Related Macular Degeneration (ARMD) with bevacizumab. The main object of the thesis was to evaluate the viability of less frequent bevacizumab dosage regiments. Furthermore, the reactivation interval of CNV was observed, and we delved deeper into a specific kind of CNV and its characteristics using a
openaire   +1 more source

Current perspectives on ranibizumab

Clinical Ophthalmology, 2015
Vaidehi S Dedania,1 Sophie J Bakri21Department of Ophthalmology, Albany Medical Center, Lions Eye Institute, Albany, NY, USA; 2Department of Ophthalmology, Mayo Clinic, Rochester, MN, USABackground: This review summarizes the Phase III studies addressing
Dedania VS, Bakri SJ
doaj  

Functional Outcomes of the Low Vision Depression Prevention Trial in Age-Related Macular Degeneration. [PDF]

, 2017
Purpose: To compare the efficacy of behavioral activation (BA) plus low vision rehabilitation with an occupational therapist (OT-LVR) with supportive therapy (ST) on visual function in patients with age-related macular degeneration (AMD). Methods: Single-
Casten, Robin J., Deemer, Ashley D., Massof, Robert W., Piersol, Catherine V., Rovner, Barry W.   +4 more
core   +3 more sources

Continuity of care and risk of vision loss in patients with newly developed macular degeneration

Acta Ophthalmologica, Volume 104, Issue 1, Page e39-e47, February 2026.
Abstract Purpose Neovascular age‐related macular degeneration (AMD) is a major cause of vision loss. Effective treatment requires sustained care, which may be influenced by continuity of care (COC). Understanding this association is crucial for improving patient outcomes.
In Hwan Cho, Minah Park, Dae Joong Ma, In Hwan Hong, Hyunkyu Kim, Seung Hoon Kim   +5 more
wiley   +1 more source

Treatment of neovascular age-related macular degeneration: Current therapies

Clinical Ophthalmology, 2009
Albert J Augustin, Stefan Scholl, Janna KirchhofDepartment of Ophthalmology, Klinikum Karlsruhe, GermanyAbstract: Choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD) is now the leading cause of blindness and severe ...
Albert J Augustin, Stefan Scholl, Janna Kirchhof   +2 more
doaj  

Long-Term Follow-Up of Dry Age-Related Macular Degeneration Patients

Journal of Current Ophthalmology
Purpose: To assess the progression rate from dry age-related macular degeneration (dAMD) to advanced AMD and possible risk factors. Methods: Demographics, medical and ocular conditions, baseline eye examinations, optical coherence tomography features ...
Elham Sadeghi, Golnoush Mahmoudinezhad, Nicola Valsecchi, Sharat Chandra Vupparaboina, Sandeep Chandra Bollepalli, Kiran Kumar Vupparaboina, Jose-Alain Sahel, Andrew W. Eller, Jay Chhablani   +8 more
doaj   +1 more source

Treatment of neovascular age-related macular degeneration in patients with diabetes

Clinical Ophthalmology, 2008
Michael Cummings1, José Cunha-Vaz21Academic Department of Diabetes and Endocrinology, Queen Alexandra Hospital, Portsmouth, UK; 2Department of Ophthalmology, University Hospital of Coimbra, Centre of Ophthalmology, Institute of Biomedical ...
Michael Cummings, José Cunha-Vaz   +1 more
doaj  

Durability and Efficacy of Faricimab in Treatment-Resistant Retinal Edema Utilizing “Real-World” Dosing Regimens

Journal of Ophthalmology
Conclusions: In “treatment-resistant” patients receiving anti-VEGF therapy for neovascular age-related macular degeneration or diabetic macular edema, switching to IFI in a “real-world” TAE protocol led to statistically significant improvements in ...
Shravan V. Savant, James T. Kwan, Fina Barouch, Jeffrey Chang, David J. Ramsey, Jeffrey Marx, Gregory Blaha, Kendra Klein-Mascia   +7 more
doaj   +1 more source